ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,369Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 890

$853K Total Retail Price of All Prescriptions

Rank: 80 out of 890

657 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 657 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

16% of this provider’s 657 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 14,371 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 597 561 1 1
FUROSEMIDE 593 551 2 7
OMEPRAZOLE 490 464 3 8
LISINOPRIL 381 325 4 4
POTASSIUM CHLORIDE 381 366 4 11
METFORMIN HCL 374 287 6 6
HYDROCODONE-ACETAMINOPHEN 374 270 S3 6 3
TRAMADOL HCL 313 288 8 16
TRIAMTERENE-HCTZ 285 256 9 61
METOPROLOL TARTRATE 248 210 10 15
DIOVAN 242 234 11 33
LEVOTHYROXINE SODIUM 239 213 12 2
LACTULOSE 202 174 13 112
NAMENDA 189 189 14 36
CITALOPRAM HBR 188 176 15 20
CLOPIDOGREL 188 186 15 28
WARFARIN SODIUM 187 151 17 24
HYDROCHLOROTHIAZIDE 186 176 18 9
NEXIUM 179 129 19 14
PANTOPRAZOLE SODIUM 179 144 19 34
CARVEDILOL 177 156 21 22
ZOLPIDEM TARTRATE 168 138 22 19
ESCITALOPRAM OXALATE 164 146 23 51
POLYETHYLENE GLYCOL 3350 158 158 24 67
GABAPENTIN 157 141 25 12
PRAVASTATIN SODIUM 154 136 26 10
BENAZEPRIL HCL 152 151 27 44
DICLOFENAC POTASSIUM 149 126 28 221
SPIRIVA 140 136 29 66
SIMVASTATIN 137 123 30 5
ISOSORBIDE MONONITRATE ER 131 122 31 60
METOPROLOL SUCCINATE 125 119 32 17
FLUTICASONE PROPIONATE 116 88 33 39
CIPROFLOXACIN HCL 113 90 34 58
MELOXICAM 110 105 35 18
PLAVIX 108 97 36 42
DONEPEZIL HCL 106 106 37 30
ALBUTEROL SULFATE 105 105 38 162
GLIPIZIDE ER 105 100 38 110
PREDNISONE 104 83 40 47
GLIPIZIDE XL 104 76 40 128
RAMIPRIL 94 71 42 80
FLUOXETINE HCL 94 58 42 63
BISOPROLOL-HYDROCHLOROTHIAZIDE 92 85 44 122
NITROFURANTOIN MONO-MACRO 92 89 44 181
DIGOXIN 91 76 46 65
LYRICA 89 86 47 71
NYSTATIN-TRIAMCINOLONE 87 72 48 277
SPIRONOLACTONE 85 78 49 85
ATENOLOL 85 55 49 23
CEFDINIR 85 74 49 191
CYMBALTA 83 78 52 45
SULFAMETHOXAZOLE-TRIMETHOPRIM 82 62 53 76
ATORVASTATIN CALCIUM 81 75 54 13
BACLOFEN 81 66 54 161
AMOX TR-POTASSIUM CLAVULANATE 80 58 56 132
CELEBREX 79 68 57 91
LOVASTATIN 78 68 58 46
ADVAIR DISKUS 76 76 59 52
SOTALOL 76 76 59 269
GEMFIBROZIL 74 45 61 103
GLIMEPIRIDE 72 52 62 27
AMLODIPINE BESYLATE-BENAZEPRIL 71 67 63 41
TAMSULOSIN HCL 69 43 64 32
QUETIAPINE FUMARATE 69 69 64 73
DIOVAN HCT 69 68 64 48
CRESTOR 68 57 67 25
SINGULAIR 68 62 67 79
HYDRALAZINE HCL 65 65 69 100
AZITHROMYCIN 65 55 69 37
BISOPROLOL FUMARATE 65 62 69 163
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 46 69 21
DICLOFENAC SODIUM 64 61 73 96
GLIPIZIDE 64 55 73 62
TRIAMCINOLONE ACETONIDE 63 61 75 160
VENLAFAXINE HCL ER 62 46 76 114
AMIODARONE HCL 58 46 77 206
LANSOPRAZOLE 58 58 77 171
ENALAPRIL MALEATE 57 56 79 56
AMITRIPTYLINE HCL 56 52 R 80 43
LEXAPRO 54 47 81 186
HYDROXYZINE HCL 52 44 R 82 200
ALLOPURINOL 51 40 83 31
ESTRADIOL 51 28 R 83 118
TRAZODONE HCL 51 33 83 40
NOVOLOG MIX 70-30 FLEXPEN 51 51 83 262
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.